Source: Eur Respir J 2012; 39: 1534-1535
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Frydman Nelly, Steffann Julie, Girerd Barbara, Frydman René, Munnich Arnold, Simonneau Gérald, Humbert Marc. Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation. Eur Respir J 2012; 39: 1534-1535

Member's Comments

No comment yet.

Related content which might interest you: Screening of pulmonary arterial hypertension in BMPR2 mutation carriers Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020 Clinical characteristics, hemodynamics and survival in idiopathic and familial pulmonary arterial hypertension with germline BMPR2 mutation Source: Eur Respir J 2007; 30: Suppl. 51, 250s Year: 2007 Clinical manifestation of hereditary pulmonary arterial hypertension by a ²second hit² mutation in the genes BMPR2 and EIF2AK4 Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Relationship of BMPR2 mutations and vasoreactivity in pulmonary arterial hypertension Source: Research Seminar 2005 - Pulmonary Circulation: Molecular Determinants of Pulmonary Vascular Remodelling Year: 2005 Pulmonary arterial hypertension preceding idiopathic pulmonary fibrosis in a BMPR2 mutation positive patient Source: Eur Respir Rev 2014; 23: 147-149 Year: 2014 Familial pulmonary arterial hypertension by KDR heterozygous loss of function Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019 Year: 2020 Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation Source: Eur Respir J, 55 (5) 1902340; 10.1183/13993003.02340-2019 Year: 2020 BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1668-1681 Year: 2016 Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients Source: Eur Respir J 2012; 39: 597-603 Year: 2012 BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Molecular analysis of genes BMPR2 and KCNA5 in Spanish patients with pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Functional characterization of BMPR2 gene in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Clinical presentation, hemodynamical characteristics and survival of patients with pulmonary arterial hypertension carrying or not a BMPR2 mutation Source: Eur Respir J 2005; 26: Suppl. 49, 352s Year: 2005 Diffusion capacity and BMPR2 mutations in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 1195-1198 Year: 2014 Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution Source: Eur Respir J 2012; 39: 1292-1293 Year: 2012 Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene Source: Eur Respir J 2001; 17: 1065-1069 Year: 2001 A new molecular genetic diagnostic approach for pulmonary arterial hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016